MESOBLAST LTD

MESO - Company ID 0001345099

Market cap$1.99 B

Rank#2143

Filings576

MESOBLAST LTD has filed 576 public company documents between 2005 and 2026. The most frequent type is 6-k (399 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchMESO overview$1.99 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2143See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut MESO beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow MESO via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	2mo ago2026-04-30	2026-04-30	View filing
6-K	6-K	2mo ago2026-04-29	2026-04-29	View filing
3	New insider ownership	2mo ago2026-04-29	2026-03-18	View filing
6-K	6-K	2mo ago2026-04-17	2026-04-17	View filing
6-K	6-K	2mo ago2026-04-15	2026-04-15	View filing
4	Insider trade	2mo ago2026-04-13	2026-04-09	View filing
4	Insider trade	3mo ago2026-04-10	2026-04-09	View filing
6-K	6-K	3mo ago2026-04-08	2026-04-08	View filing
6-K	6-K	3mo ago2026-04-08	2026-04-08	View filing
6-K	6-K	3mo ago2026-04-08	2026-04-08	View filing
6-K	6-K	3mo ago2026-04-08	2026-04-08	View filing
3	New insider ownership	3mo ago2026-04-01	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-01	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-01	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-23	2026-03-18	View filing
6-K	6-K	3mo ago2026-03-23	2026-03-23	View filing
6-K	6-K	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-18	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-16	2026-03-16	View filing
6-K	6-K	3mo ago2026-03-13	2026-03-12	View filing
6-K	6-K	3mo ago2026-03-12	2026-03-12	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	4mo ago2026-03-11	-	View filing
6-K	6-K	4mo ago2026-02-27	2026-02-27	View filing
6-K	6-K	4mo ago2026-02-27	2025-12-31	View filing
6-K	6-K	4mo ago2026-02-23	2026-02-23	View filing
6-K	6-K	4mo ago2026-02-12	2026-02-12	View filing
6-K	6-K	5mo ago2026-01-29	2026-01-29	View filing
6-K	6-K	5mo ago2026-01-28	2026-01-28	View filing
6-K	6-K	5mo ago2026-01-21	2026-01-19	View filing
6-K	6-K	5mo ago2026-01-16	2026-01-16	View filing
EFFECT	EFFECT	5mo ago2026-01-14	-	View filing
6-K	6-K	5mo ago2026-01-14	2026-01-14	View filing
424B3	424B3	5mo ago2026-01-14	-	View filing
6-K	6-K	5mo ago2026-01-13	2026-01-12	View filing
6-K	6-K	6mo ago2026-01-09	2026-01-09	View filing
6-K	6-K	6mo ago2026-01-07	2026-01-07	View filing
6-K	6-K	6mo ago2026-01-02	2026-01-02	View filing

MESOBLAST LTD

Similar companies to research next

Year